Inhaled Uprima Impotence Drug May Make Comeback
Written by Richard Simmons | Tuesday, 18 May 2010 | There is 1 comment
was able to produce erections in men after as little as 10 minutes
You might remember a few years ago there was a lot of hype about the drug called Uprima which was marketed as an erectile dysfunction treatment that not only boosted the ability to have sex like Viagra, Cialis and Levitra but also boosted the desire. The drug which worked by acting on chemical receptors the brain was called apomorphine was taken in the form of a tablet but unfortunately because it had very poor sales due to poor effectiveness it was soon discontinued.
It now appears that an attempt is being made to relaunch the apomorphine medication, but this time it will not come in a tablet form but will be dispensed using an inhaler. This will mean that it will have an effect almost instantaneously and could make the drug a viable and useful medication for men suffering from different types of erectile dysfunction which cannot be treated with Viagra, Cialis and Levitra.
Vectura Ltd which is based in the UK said that in their own trials they had shown that the inhaled apomorphine was able to produce erections in men after as little as 10 minutes.
The vast majority of men who suffer from erectile dysfunction do so because of problems with arterial health especially in penile artery. Viagra, Cialis and Levitra widen arteries and that is why they work so effectively. In some cases men are unable to get erections because they suffer from low levels of sexual desire and this is where Vectura Ltd hope the apomorphine drug may be effective.
It is also possible that the drug could work effectively for women who suffer from lower levels of sexual desire than men do, however at present Vectura Ltd is focusing on the treatment for men.
Apomorphine which was originally researched as a possible treatment for Parkinson's disease remains a potentially revolutionary drug in the field of both erectile dysfunction and female sexual dysfunction but more study needs to be done before it comes to the market and it is likely to be many years before you see it in a pharmacy.
